Similarly, miR-940 from PC and BC cells was reported to facilitate osteoblastic lesions by targeting Rho-GTPase-activating protein 1 (ARHGAP1) and family with sequence-similarity 134, member A (FAM134A) [158]. Here, ARHGAP1 is linked to breast cancer.